- Connected sensors,
- Integrated devices
Connected Injectable Drug Delivery Devices Market size was valued at USD 397.2 million in 2022 and is expected to reach USD 4,468.9 million by 2029, growing a CAGR of 35.4% from 2023-2029. The prevalence of chronic diseases is likely to affect the growth of the market size of connected drug-delivery devices. Continuous product innovation, multiple products in pipeline and mergers, and joint initiatives are some factors that help increase market share across the map for connected drug delivery devices. At the same time, problems arising from excessive use of nasal sprays could limit the growth of the market. In addition, local side effects risk, and decreased bioavailability are also factors that hamper market development. This study analyses the global connected injectable drug delivery devices market dynamics in a detailed manner to identify current trends and drivers, growth opportunities, and potential challenges to the key stakeholders in the operating market. In addition, PBI has analyzed the global market to better equip customers with possible investment opportunities across regions and consumer unmet needs. Key stakeholders of the global assisted reproductive technology include suppliers, manufacturers, marketers, policymakers, and service providers engaged in the global assisted reproductive technology market.
Connected Injectable Drug Delivery Devices Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
35.4%
Largest Market
Asia-Pacific
Fastest Growing Market
North-America
Connected Injectable Drug Delivery Devices Market Dynamics
Growing population of patients and rising unmet medical needs, increasing demand for healthcare services, result in increased cost pressure on global healthcare systems. This is expected to boost the global demand for connected injectable drug delivery devices in the coming years. For example, rheumatoid arthritis (RA) affected more than 1.5 million people in the U.S. in 2017, according to the American Arthritis Association. Similarly, a rise in the incidence of diabetes is projected to drive the global demand for connected injectable drug delivery devices in the immediate future.
North-America Got Significant Share
Connected Injectable Drug Delivery Devices Market Regional Analysis
Owing to technological developments in the pharmaceutical industry and a high rate of product adoption in the region, North America dominates the global market for injectable drug delivery devices. Asia Pacific is expected to be the most lucrative market for connected injectable drug delivery devices in the near future, owing to ongoing medical infrastructure growth, increased adoption of technologically advanced surgical procedures and increased government initiatives in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Connected Injectable Drug Delivery Devices Market Segmentation
By Device Type
By Technology
- Bluetooth
- Near field communication
- Service
By Application
- Anaphylaxis
- Respiratory
- Cardiovascular
- Diabetes
- Hormone Replacement
- Others
By End User
- Hospital,
- Clinics,
- Homecare,
- Others
Frequently Asked Questions
The connected injectable drug delivery devices market size was valued at USD 397.2 million in 2022
Ypsomed Holdings, Unolife Corporation, Quito Technologies, Phillips-Medisize Corporation, SHL Group
The connected injectable drug delivery devices market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The connected injectable drug delivery devices market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Connected Injectable Drug Delivery Devices Market Introduction |
| 2.1. Global Connected Injectable Drug Delivery Devices Market Taxonomy |
| 2.2. Global Connected Injectable Drug Delivery Devices Market Definitions |
| 2.2.1. By Device Type |
| 2.2.2. By Technology |
| 2.2.3. By Application |
| 2.2.4. By End User |
| 2.2.5. By Region |
| 3. Global Connected Injectable Drug Delivery Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Connected Injectable Drug Delivery Devices Market Dynamic Factors - Impact Analysis |
| 3.6. Global Connected Injectable Drug Delivery Devices Market Competition Landscape |
| 4. Global Connected Injectable Drug Delivery Devices Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Connected Injectable Drug Delivery Devices Market, By Device Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1. Connected Sensors |
| 5.1.1. Connected inhalation sensors |
| 5.1.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.1.3. Market Opportunity Analysis |
| 5.1.2. Connected injectable sensors |
| 5.1.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.2.3. Market Opportunity Analysis |
| 5.2. Integrated Devices |
| 5.2.1. Integrated inhalation devices |
| 5.2.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.1.3. Market Opportunity Analysis |
| 5.2.2. Integrated injectable devices |
| 5.2.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.2.3. Market Opportunity Analysis |
| 6. Global Connected Injectable Drug Delivery Devices Market, By Technology, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1. Bluetooth |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Near Field Communication |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Service |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Connected Injectable Drug Delivery Devices Market, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1. Anaphylaxis |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Respiratory |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Cardiovascular |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Diabetes |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Hormone Replacement |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Others |
| 7.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 8. Global Connected Injectable Drug Delivery Devices Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1. Hospital |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Clinic |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Homecare |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Global Connected Injectable Drug Delivery Devices Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Connected Injectable Drug Delivery Devices Market - Opportunity Analysis Index, By Device Type, By Technology, By Application, By End User, and Region, 2023 - 2029 |
| 10. North America Connected Injectable Drug Delivery Devices Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 10.1. Device Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Connected sensors |
| 10.1.1.1. Connected inhalation sensors |
| 10.1.1.2. Connected injectable sensors |
| 10.1.2. Integrated devices |
| 10.1.2.1. Integrated inhalation devices |
| 10.1.2.2. Integrated injectable devices |
| 10.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Bluetooth |
| 10.2.2. Near field communication |
| 10.2.3. Service |
| 10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Anaphylaxis |
| 10.3.2. Respiratory |
| 10.3.3. Cardiovascular |
| 10.3.4. Diabetes |
| 10.3.5. Hormone Replacement |
| 10.3.6. Others |
| 10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Hospital |
| 10.4.2. Clinics |
| 10.4.3. Homecare |
| 10.4.4. Others |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Connected Injectable Drug Delivery Devices Market - Opportunity Analysis Index, By Device Type, By Technology, By Application, By End User, and Country, 2023 - 2029 |
| 10.7. North America Connected Injectable Drug Delivery Devices Market Dynamics Trends |
| 11. Europe Connected Injectable Drug Delivery Devices Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 11.1. Device Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Connected sensors |
| 11.1.1.1. Connected inhalation sensors |
| 11.1.1.2. Connected injectable sensors |
| 11.1.2. Integrated devices |
| 11.1.2.1. Integrated inhalation devices |
| 11.1.2.2. Integrated injectable devices |
| 11.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Bluetooth |
| 11.2.2. Near field communication |
| 11.2.3. Service |
| 11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Anaphylaxis |
| 11.3.2. Respiratory |
| 11.3.3. Cardiovascular |
| 11.3.4. Diabetes |
| 11.3.5. Hormone Replacement |
| 11.3.6. Others |
| 11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Hospital |
| 11.4.2. Clinics |
| 11.4.3. Homecare |
| 11.4.4. Others |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Rest of Europe |
| 11.6. Europe Connected Injectable Drug Delivery Devices Market - Opportunity Analysis Index, By Device Type, By Technology, By Application, By End User, and Country, 2023 - 2029 |
| 11.7. Europe Connected Injectable Drug Delivery Devices Market Dynamics Trends |
| 12. Asia-Pacific Connected Injectable Drug Delivery Devices Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 12.1. Device Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Connected sensors |
| 12.1.1.1. Connected inhalation sensors |
| 12.1.1.2. Connected injectable sensors |
| 12.1.2. Integrated devices |
| 12.1.2.1. Integrated inhalation devices |
| 12.1.2.2. Integrated injectable devices |
| 12.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Bluetooth |
| 12.2.2. Near field communication |
| 12.2.3. Service |
| 12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Anaphylaxis |
| 12.3.2. Respiratory |
| 12.3.3. Cardiovascular |
| 12.3.4. Diabetes |
| 12.3.5. Hormone Replacement |
| 12.3.6. Others |
| 12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Hospital |
| 12.4.2. Clinics |
| 12.4.3. Homecare |
| 12.4.4. Others |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. China |
| 12.5.2. India |
| 12.5.3. Japan |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Connected Injectable Drug Delivery Devices Market - Opportunity Analysis Index, By Device Type, By Technology, by Device Type, By End User, and Country, 2023 - 2029 |
| 12.7. Asia-Pacific Connected Injectable Drug Delivery Devices Market Dynamics Trends |
| 13. Latin America Connected Injectable Drug Delivery Devices Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 13.1. Device Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Connected sensors |
| 13.1.1.1. Connected inhalation sensors |
| 13.1.1.2. Connected injectable sensors |
| 13.1.2. Integrated devices |
| 13.1.2.1. Integrated inhalation devices |
| 13.1.2.2. Integrated injectable devices |
| 13.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Bluetooth |
| 13.2.2. Near field communication |
| 13.2.3. Service |
| 13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Anaphylaxis |
| 13.3.2. Respiratory |
| 13.3.3. Cardiovascular |
| 13.3.4. Diabetes |
| 13.3.5. Hormone Replacement |
| 13.3.6. Others |
| 13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Hospital |
| 13.4.2. Clinics |
| 13.4.3. Homecare |
| 13.4.4. Others |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Rest of Latin America |
| 13.6. Latin America Connected Injectable Drug Delivery Devices Market - Opportunity Analysis Index, By Device Type, By Technology, By Application, By End User, and Country, 2023 - 2029 |
| 13.7. Latin America Connected Injectable Drug Delivery Devices Market Dynamics Trends |
| 14. Middle East and Africa Connected Injectable Drug Delivery Devices Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 14.1. Device Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Connected sensors |
| 14.1.1.1. Connected inhalation sensors |
| 14.1.1.2. Connected injectable sensors |
| 14.1.2. Integrated devices |
| 14.1.2.1. Integrated inhalation devices |
| 14.1.2.2. Integrated injectable devices |
| 14.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Bluetooth |
| 14.2.2. Near field communication |
| 14.2.3. Service |
| 14.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Anaphylaxis |
| 14.3.2. Respiratory |
| 14.3.3. Cardiovascular |
| 14.3.4. Diabetes |
| 14.3.5. Hormone Replacement |
| 14.3.6. Others |
| 14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Hospital |
| 14.4.2. Clinics |
| 14.4.3. Homecare |
| 14.4.4. Others |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf CoEnd User Council (GCC) Countries |
| 14.5.2. South Africa |
| 14.5.3. Rest of MEA |
| 14.6. MEA Connected Injectable Drug Delivery Devices Market - Opportunity Analysis Index, By Device Type, By Technology, By Application, By End User, and Country, 2023 - 2029 |
| 14.7. MEA Connected Injectable Drug Delivery Devices Market Dynamics Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Key Device Types, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Ypsomed Holdings |
| 15.2.2. Unolife Corporation |
| 15.2.3. Quio Technologies |
| 15.2.4. Phillips-Medisize Corporation |
| 15.2.5. SHL Group |
| 15.2.6. Biocorp |
| 15.2.7. Haselmeier Inc. |
| 15.2.8. West Pharmaceutical Services Inc. |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
- Ypsomed Holdings
- Unolife Corporation
- Quio Technologies
- Phillips-Medisize Corporation
- SHL Group
- Biocorp
- Haselmeier Inc.
- West Pharmaceutical Services Inc.